Press release
Pleural Diseases Market to Show Remarkable Growth Trends from 2023 to 2032, DelveInsight Reports | Lung Therapeutics, Angiotech Pharmaceuticals, Clover Biopharma
To Know in detail about the Pleural Diseases market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pleural Diseases Market Forecast
https://www.delveinsight.com/sample-request/pleural-diseases-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Pleural Diseases Market Report:
• The Pleural Diseases market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• The FDA granted approval for the use of Skytrofa (lonapegsomatropin) in September 2021 for the treatment of pediatric patients aged one year and older who weigh at least 11.5 kg and have growth failure as a result of insufficient endogenous growth hormone secretion
• The study by Rogol stated that GHD in children is a relatively rare condition. In the United States, it was estimated to occur in approximately 1 in 3500 to 4000 children
• As per National Institute for Health and Clinical Excellence (NICE), the prevalence of growth hormone deficiency was estimated to be between 1 in 3500 and 1 in 4000 children
• In about half of the children with growth hormone deficiency (50%), the cause is unknown (idiopathic growth hormone deficiency)
• Key Pleural Diseases Companies: Istituto Oncologico Veneto, RS Oncology, PrECOG, LLC, AstraZeneca, Oncotelic Inc., Trizell Ltd, MedImmune LLC, Sanofi, and others
• Key Pleural Diseases Therapies: Carboplatin, RSO-021, Durvalumab, Volrustomig, OT-101, rAd-IFN, Tremelimumab, THOR-707, and others.
• The Pleural Diseases market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Pleural Diseases pipeline products will significantly revolutionize the Pleural Diseases market dynamics.
Pleural Diseases Overview:
Pleural diseases refer to medical conditions that affect the pleura, the thin membrane surrounding the lungs and lining the chest cavity. Common pleural diseases include pleurisy (inflammation of the pleura), pleural effusion (excess fluid in the pleural space), pneumothorax (collapsed lung), and pleural thickening. These conditions can result from infections, injuries, cancers, or autoimmune disorders and often cause symptoms like chest pain, shortness of breath, and coughing. Diagnosis and treatment depend on the underlying cause and severity of the condition.
Get a Free sample for the Pleural Diseases Market Report:
https://www.delveinsight.com/report-store/pleural-diseases-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Pleural Diseases Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Pleural Diseases Epidemiology Segmentation:
The Pleural Diseases market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Pleural Diseases
• Prevalent Cases of Pleural Diseases by severity
• Gender-specific Prevalence of Pleural Diseases
• Diagnosed Cases of Episodic and Chronic Pleural Diseases
Download the report to understand which factors are driving Pleural Diseases epidemiology trends @ Pleural Diseases Epidemiology Forecast
https://www.delveinsight.com/sample-request/pleural-diseases-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Pleural Diseases Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Pleural Diseases market or expected to get launched during the study period. The analysis covers Pleural Diseases market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Pleural Diseases Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Pleural Diseases Therapies and Key Companies
• Carboplatin: Istituto Oncologico Veneto
• RSO-021: RS Oncology
• Durvalumab: PrECOG, LLC.
• Volrustomig: AstraZeneca
• OT-101: Oncotelic Inc.
• rAd-IFN: Trizell Ltd
• Tremelimumab: MedImmune LLC
• THOR-707: Sanofi
Discover more about therapies set to grab major Pleural Diseases market share @ Pleural Diseases Treatment Market
https://www.delveinsight.com/sample-request/pleural-diseases-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Scope of the Pleural Diseases Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Pleural Diseases Companies: Istituto Oncologico Veneto, RS Oncology, PrECOG, LLC, AstraZeneca, Oncotelic Inc., Trizell Ltd, MedImmune LLC, Sanofi, and others
• Key Pleural Diseases Therapies: Carboplatin, RSO-021, Durvalumab, Volrustomig, OT-101, rAd-IFN, Tremelimumab, THOR-707, and others
• Pleural Diseases Therapeutic Assessment: Pleural Diseases current marketed and Pleural Diseases emerging therapies
• Pleural Diseases Market Dynamics: Pleural Diseases market drivers and Pleural Diseases market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Pleural Diseases Unmet Needs, KOL's views, Analyst's views, Pleural Diseases Market Access and Reimbursement
To know more about Pleural Diseases companies working in the treatment market, visit @ Pleural Diseases Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/pleural-diseases-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Pleural Diseases Market Report Introduction
2. Executive Summary for Pleural Diseases
3. SWOT analysis of Pleural Diseases
4. Pleural Diseases Patient Share (%) Overview at a Glance
5. Pleural Diseases Market Overview at a Glance
6. Pleural Diseases Disease Background and Overview
7. Pleural Diseases Epidemiology and Patient Population
8. Country-Specific Patient Population of Pleural Diseases
9. Pleural Diseases Current Treatment and Medical Practices
10. Pleural Diseases Unmet Needs
11. Pleural Diseases Emerging Therapies
12. Pleural Diseases Market Outlook
13. Country-Wise Pleural Diseases Market Analysis (2019-2032)
14. Pleural Diseases Market Access and Reimbursement of Therapies
15. Pleural Diseases Market drivers
16. Pleural Diseases Market barriers
17. Pleural Diseases Appendix
18. Pleural Diseases Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Pleural Diseases Pipeline
"Pleural Diseases Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Pleural Diseases market. A detailed picture of the Pleural Diseases pipeline landscape is provided, which includes the disease overview and Pleural Diseases treatment guidelines.
Pleural Diseases Epidemiology
DelveInsight's 'Pleural Diseases Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Pleural Diseases epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Cart-related Neurotoxicity Market https://www.delveinsight.com/report-store/cart-related-neurotoxicity-nt-market
DelveInsight's "CART-related Neurotoxicity Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the CART-related Neurotoxicity, historical and forecasted epidemiology as well as the CART-related Neurotoxicity market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market
DelveInsight's "Crows Feet Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Crows Feet, historical and forecasted epidemiology as well as the Crows Feet market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Herpes Simplex Virus Market
https://www.delveinsight.com/report-store/herpes-simplex-market
DelveInsight's "Herpes Simplex Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Herpes Simplex, historical and forecasted epidemiology as well as the Herpes Simplex market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hypercoagulability Market
https://www.delveinsight.com/report-store/hypercoagulability-market
DelveInsight's "Hypercoagulability- Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hypercoagulability, historical and forecasted epidemiology as well as the Hypercoagulability market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pleural Diseases Market to Show Remarkable Growth Trends from 2023 to 2032, DelveInsight Reports | Lung Therapeutics, Angiotech Pharmaceuticals, Clover Biopharma here
News-ID: 3692050 • Views: …
More Releases from DelveIinsight Business Research
Thymidine Kinase 2 Deficiency Market Insights: Unmet Needs and Emerging Therapie …
The Thymidine Kinase 2 deficiency (TK2d) market is poised for substantial growth in the coming decade, fueled by increasing awareness of this rare genetic disorder and the development of promising therapies like MT1621 (UCB).
DelveInsight's "Thymidine Kinase 2 Deficiency Market Insight, Epidemiology and Market Forecast - 2034" report delivers comprehensive insights into the current TK2d landscape and future market trends across the 7MM (United States, EU4, the United Kingdom, and Japan).…
Pigment Epithelial Detachment Market Outlook: Aging Population, AI-Driven Diagno …
Recent analysis by DelveInsight indicates that the retinal pigment epithelium market is poised for notable growth, with the 7MM expected to achieve a respectable CAGR. This growth is being fueled by several factors, including an aging population, advancements in AI-driven diagnosis, industry collaborations, and novel therapeutic options. Key retinal pigment epithelium companies include Sumitomo Pharma, Healios K.K., Eyestem Research, Luxa Biotechnology, Regenerative Patch Technologies, Lineage Cell Therapeutics, Katairo GmbH, Visgenx…
Chronic Obstructive Pulmonary Disease Market Forecast 2024-2034: Competitive Int …
The chronic obstructive pulmonary disease (COPD) market is projected to experience steady growth in the coming years, driven primarily by increasing diagnosed prevalent cases and the introduction of novel biologics and combination therapies by key COPD companies, including Sanofi, Regeneron Pharmaceuticals, GlaxoSmithKline, AstraZeneca, and Amgen, among others. This market expansion reflects advancements in targeted therapeutic approaches, particularly for patients with specific phenotypes, improved diagnostic capabilities, and rising awareness among healthcare…
Blastic Plasmacytoid Dendritic Cell Neoplasm Treatment Landscape Transforms with …
The Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) market across the 7MM is poised for significant growth through 2034. This growth is driven by advancements in targeted therapies, increased awareness of the disease among healthcare professionals, and ongoing research and development efforts. Major pharmaceutical and biotech companies, including AbbVie, ImmunoGen, Mustang Bio, Genentech, Stemline Therapeutics, Jazz Pharmaceuticals, Menarini Group, Cellex Patient Treatment GmbH, and Xencor, are actively engaged in the BPDCN…
More Releases for Pleural
Pleural Effusion Market Emerging Trends and Growth Prospects 2034
Introduction
Pleural effusion, a condition characterized by the accumulation of excess fluid in the pleural cavity, often results from underlying diseases such as malignant tumors, heart failure, and infections. This condition can significantly impair respiratory function and lead to symptoms like shortness of breath, chest pain, and coughing. The global burden of pleural effusion is rising, particularly due to the increasing prevalence of lung cancer, heart disease, and chronic respiratory diseases.
The…
Malignant Pleural Effusion Pipeline Therapeutics Assessment Report 2024 (Updated …
DelveInsight's, "Malignant Pleural Effusion Pipeline Insight 2024" report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Malignant Pleural Effusion pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Malignant Pleural Effusion Research.…
Pleural Drainage Catheters Market Size 2024 to 2031.
Market Overview and Report Coverage
A Pleural Drainage Catheter is a medical device used to drain fluid or air from the pleural cavity surrounding the lungs. These catheters are commonly used in patients suffering from conditions such as pneumonia, lung cancer, or pleural effusion.
The Pleural Drainage Catheters Market is expected to witness significant growth in the coming years, with a projected CAGR of 7.80% during the forecasted period. This…
Pleural Drainage Catheters Market Will Generate Record Revenue by 2031
Pleural Drainage Catheters Market size was valued at USD billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 14.88% from 2024 to 2030. The Pleural Drainage Catheters Market is witnessing a significant surge, driven by a myriad of factors including the rising prevalence of respiratory disorders, advancements in catheter technology, and increasing demand for minimally invasive treatment options. This article explores the latest…
Global Pleural Effusion Drug Market - Industry Trends and Forecast to 2028
Global Pleural Effusion Drug Market - Industry Trends and Forecast to 2028
The pleural effusion drug market is expected to gain market growth at a potential rate of 4.70% in the forecast period of 2021 to 2028. Increase in prevalence rate of pleural effusion worldwide is the vital factor escalating the pleural effusion drug market growth.
Pleural effusion is a type of condition in which excessive fluids build-up or accumulates in the…
Malignant Pleural Effusions to Gain Maximum Traction in Pleural Catheters Market …
250 Pages Pleural Catheters Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider
According to Fact MR’s recent market research, sales of Pleural Catheters to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.
Focus on…
